(Q33371531)

26 July 2017

1 reference

title

Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia (English)

1 reference

26 July 2017

David S Goldfarb

2

0 references

David E Leaf

object named as

David E Leaf

series ordinal

1

0 references

language of work or name

English

0 references

publication date

27 August 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

75

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

15-24

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2008.414

26 July 2017

exact match

0 references

cites work

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The prevalence of anemia in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Anemia as independent predictor of major events in elderly patients with chronic angina

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Methods and problems in measuring quality of life

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Trends in anemia management among US hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

A disease-specific questionnaire for assessing quality of life in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Defining clinically meaningful change in health-related quality of life.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The minimum clinically important difference in physician-assigned visual analog pain scores

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Relation of implicit theories to the construction of personal histories

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Interpretation of quality of life changes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Once-weekly epoetin alfa for treating the anemia of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Quality of life assessment in a recent haemoglobin trial in CKD (CHOIR)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Working capacity is increased following recombinant human erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Treatment of anaemia in haemodialysis patients with erythropoietin: long-term effects on exercise capacity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Effects of the correction of renal anaemia by erythropoietin on physiological changes during exercise

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Improvement of brain function in hemodialysis patients treated with erythropoietin.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Administration and interpretation of the Trail Making Test

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Normalizing hematocrit in dialysis patients improves brain function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The Relationship Between Patient Knowledge of Hemoglobin Levels and Health-Related Quality of Life

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.414

7 January 2021

Identifiers

DOI

10.1038/KI.2008.414

1 reference

Dimensions Publication ID

26 July 2017

1009269040

0 references

1 reference